Kiora Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: KPRX
Share price (6/3/26): $2.68
Market cap (6/3/26): $11.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Shelf registration

Ownership Filter

Alyeska Investment Group, L.P.

Nantahala Capital Management, LLC

Nantahala Capital Partners Limited Partnership

Daniels Eric Joseph

News Filter

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Announces Private Placement for Up to $24 Million Led by Perceptive Advisors

Announces Management Team Changes

Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline With Two Active Phase 2 Clinical Trials

Reports Third Quarter 2025 Results; Company Advances Pipeline With Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC